Skip to content

Clinical trials

Phase 1/2 Generalized Anxiety Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Generalized Anxiety Disorder Phase: Phase 1/2 Country / region: United States Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20121
20141
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kaiser Permanente1
Northwestern University1
University of California, San Diego1
University of South Florida1
University of Texas at Austin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Generalized Anxiety Disorder5
Anxiety Disorders3
Phobia, Social3
Anxiety, Separation2
Alzheimer Disease1
Dysthymic Disorder1
Major Depressive Disorder1
Multiple Endocrine Neoplasia Type 11
Mutism1
Obsessive-Compulsive Disorder1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.